1. Home
  2. GERN vs PLOW Comparison

GERN vs PLOW Comparison

Compare GERN & PLOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • PLOW
  • Stock Information
  • Founded
  • GERN 1990
  • PLOW 1948
  • Country
  • GERN United States
  • PLOW United States
  • Employees
  • GERN N/A
  • PLOW N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • PLOW Construction/Ag Equipment/Trucks
  • Sector
  • GERN Health Care
  • PLOW Industrials
  • Exchange
  • GERN Nasdaq
  • PLOW Nasdaq
  • Market Cap
  • GERN 700.6M
  • PLOW 718.3M
  • IPO Year
  • GERN 1996
  • PLOW 2010
  • Fundamental
  • Price
  • GERN $1.17
  • PLOW $27.91
  • Analyst Decision
  • GERN Buy
  • PLOW Buy
  • Analyst Count
  • GERN 8
  • PLOW 2
  • Target Price
  • GERN $3.71
  • PLOW $30.00
  • AVG Volume (30 Days)
  • GERN 9.2M
  • PLOW 180.6K
  • Earning Date
  • GERN 08-06-2025
  • PLOW 08-04-2025
  • Dividend Yield
  • GERN N/A
  • PLOW 4.23%
  • EPS Growth
  • GERN N/A
  • PLOW 129.47
  • EPS
  • GERN N/A
  • PLOW 2.72
  • Revenue
  • GERN $116,293,000.00
  • PLOW $587,916,000.00
  • Revenue This Year
  • GERN $161.44
  • PLOW $12.64
  • Revenue Next Year
  • GERN $53.06
  • PLOW $7.49
  • P/E Ratio
  • GERN N/A
  • PLOW $10.25
  • Revenue Growth
  • GERN 22264.04
  • PLOW 1.14
  • 52 Week Low
  • GERN $1.09
  • PLOW $21.30
  • 52 Week High
  • GERN $4.89
  • PLOW $31.98
  • Technical
  • Relative Strength Index (RSI)
  • GERN 39.34
  • PLOW 37.88
  • Support Level
  • GERN $1.20
  • PLOW $28.63
  • Resistance Level
  • GERN $1.37
  • PLOW $29.81
  • Average True Range (ATR)
  • GERN 0.08
  • PLOW 0.66
  • MACD
  • GERN -0.01
  • PLOW -0.22
  • Stochastic Oscillator
  • GERN 28.57
  • PLOW 8.27

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About PLOW Douglas Dynamics Inc.

Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.

Share on Social Networks: